See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Anthony Chan

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	36764659	0	Kumar R, Bakeer N, Dawson J, et al. Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency - first analysis of the International Society on Thrombosis and Haemostasis (ISTH) Pediatric Antithrombin Deficiency Database and Biorepository. J Thromb Haemost. 2023 Feb 8:S1538-7836(23)00100-9. doi: 10.1016/j.jtha.2023.01.037.
	36409922	0	Ding Z, Sherlock M, Chan AKC, et al. Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada. Blood Coagul Fibrinolysis. 2022 Dec 1;33(8):449-456. doi: 10.1097/MBC.0000000000001166. Epub 2022 Nov 7.
	35398856	0	Samji N, Twiss J, Chan AKC, et al. Successful Use of Thrombolysis in an Extremely Low Birth Weight, Premature Infant With Aortic Thrombosis. J Pediatr Hematol Oncol. 2022 Apr 8. pii: 00043426-990000000-00014. doi: 10.1097/MPH.0000000000002455.
	35372933	0	Ouellette AC, Darling EK, Sivapathasundaram B, et al. Incidence, Risk Factors, and Outcomes of Neonatal Renal Vein Thrombosis in Ontario: Population-Based Cohort Study. Kidney360. 2020 May 27;1(7):640-647. doi: 10.34067/KID.0000912019. eCollection 2020 Jul 30.
	35289485	0	Bhatia K, Solanki S, Paes B, et al. Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit. Pediatr Blood Cancer. 2022 Mar 15:e29668. doi: 10.1002/pbc.29668.
	35285449	0	Leong R, Patel J, Samji N, et al. Use of thrombolytic agents to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis. 2022 Mar 11. pii: 00001721-900000000-98300. doi: 10.1097/MBC.0000000000001134.
	35001043	0	Paes B, Chan AKC, Shaik M, et al. Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study. Blood Coagul Fibrinolysis. 2022 Jan 6. pii: 00001721-900000000-98313. doi: 10.1097/MBC.0000000000001110.
	34327817	0	El-Khoury H, Saifi O, Haddad S, et al. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 Nov;68(11):e29210. doi: 10.1002/pbc.29210. Epub 2021 Jul 29.
	34231501	0	Chung J, Stevic I, Gantioqui J, et al. Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography. Blood Coagul Fibrinolysis. 2021 Jul 1;32(5):305-311. doi: 10.1097/MBC.0000000000001023.
	34102656	0	Ting J, Yeung K, Paes B, et al. How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis. 2021 Jun 7. pii: 00001721-900000000-98373. doi: 10.1097/MBC.0000000000001052.
	33792176	0	van Ommen CH, Albisetti M, Bhatt M, et al. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. J Thromb Haemost. 2021 Apr;19(4):1123-1129. doi: 10.1111/jth.15260.
	33718937	0	Bhatt MD, Chan AK. Venous thrombosis in neonates. Fac Rev. 2021 Feb 25;10:20. doi: 10.12703/r/10-20. eCollection 2021.
	33555020	0	Fabritz L, Crijns HJGM, Guasch E, et al. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Europace. 2021 Mar 8;23(3):329-344. doi: 10.1093/europace/euaa279.
	33064561	0	Mian O, Matino D, Roberts R, et al. Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control Study. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620962226. doi: 10.1177/1076029620962226.
	33002131	0	Thom K, Lensing AWA, Nurmeev I, et al. Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE). Blood Adv. 2020 Oct 13;4(19):4632-4639. doi: 10.1182/bloodadvances.2020002637.
	32951663	0	Sun LR, Linds A, Sharma M, et al. Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study. Pediatr Neurol. 2020 Oct;111:59-65. doi: 10.1016/j.pediatrneurol.2020.06.002. Epub 2020 Jun 10.
	32815198	0	Biswas M, Ryan PM, Nakrani R, et al. Central venous catheters are an important factor in paediatric thrombosis. Acta Paediatr. 2021 Mar;110(3):1001-1008. doi: 10.1111/apa.15543. Epub 2020 Sep 16.
	32685899	0	van Ommen CH, Albisetti M, Chan AK, et al. The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease. Res Pract Thromb Haemost. 2020 May 25;4(5):886-892. doi: 10.1002/rth2.12352. eCollection 2020 Jul.
	32640269	0	Avila L, Amiri N, Yenson P, et al. Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing. J Pediatr. 2020 Jul 5. pii: S0022-3476(20)30835-0. doi: 10.1016/j.jpeds.2020.06.081.
	32262660	0	Leung JM, Berry LR, Atkinson HM, et al. Surface modification of poly(dimethylsiloxane) with a covalent antithrombin-heparin complex for the prevention of thrombosis: use of polydopamine as bonding agent. J Mater Chem B. 2015 Aug 7;3(29):6032-6036. doi: 10.1039/c5tb00808e. Epub 2015 Jun 29.
	32246743	0	Young G, Lensing AWA, Monagle P, et al. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation. J Thromb Haemost. 2020 Jul;18(7):1672-1685. doi: 10.1111/jth.14813. Epub 2020 Jun 4.
	31876366	0	Tieu P, Paes B, Ahmed A, et al. Inferior vena cava syndrome in neonates: An evidence-based systematic review of the literature. Pediatr Blood Cancer. 2020 Apr;67(4):e28114. doi: 10.1002/pbc.28114. Epub 2019 Dec 26.
	31699660	0	Male C, Lensing AWA, Palumbo JS, et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.
	31243691	0	Montalescot G, Brotons C, Cosyns B, et al. Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial. Am J Cardiovasc Drugs. 2020 Feb;20(1):61-71. doi: 10.1007/s40256-019-00356-2.
	30598642	0	Lensing AWA, Male C, Young G, et al. Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study. Thromb J. 2018 Dec 21;16:34. doi: 10.1186/s12959-018-0188-y. eCollection 2018.
	30534007	0	Kubitza D, Willmann S, Becka M, et al. Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study. Thromb J. 2018 Dec 4;16:31. doi: 10.1186/s12959-018-0186-0. eCollection 2018.
	30528575	0	Manlhiot C, McCrindle BW, Williams S, et al. Characterization of Post-Thrombotic Syndrome in Children with Cardiac Disease. J Pediatr. 2019 Apr;207:42-48. doi: 10.1016/j.jpeds.2018.10.064. Epub 2018 Dec 7.
	30520242	0	Bhatt MD, Patel V, Butt ML, et al. Outcomes following neonatal portal vein thrombosis: A descriptive, single-center study and review of anticoagulant therapy. Pediatr Blood Cancer. 2019 Apr;66(4):e27572. doi: 10.1002/pbc.27572. Epub 2018 Dec 5.
	30482766	0	Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27;2(22):3292-3316. doi: 10.1182/bloodadvances.2018024786.
	30410424	0	Chan A, Lensing AWA, Kubitza D, et al. Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis. Thromb J. 2018 Nov 1;16:29. doi: 10.1186/s12959-018-0182-4. eCollection 2018.
	30362248	0	Bhatt MD, Parmar N, Fowler JA, et al. Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols. Pediatr Blood Cancer. 2019 Feb;66(2):e27483. doi: 10.1002/pbc.27483. Epub 2018 Oct 25.
	29965810	0	Gantioqui J, Stevic I, Atkinson H, et al. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography. Blood Coagul Fibrinolysis. 2018 Sep;29(6):521-527. doi: 10.1097/MBC.0000000000000751.
	29781569	0	Nossair F, Schoettler P, Starr J, et al. Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature. Pediatr Blood Cancer. 2018 Sep;65(9):e27225. doi: 10.1002/pbc.27225. Epub 2018 May 21.
	29708897	0	Khatri V, Chan AKC, Stein N, et al. Conservative management of neonatal cerebral sinovenous thrombosis with coexisting thrombophilia. Blood Coagul Fibrinolysis. 2018 Jun;29(4):399-403. doi: 10.1097/MBC.0000000000000731.
	29277101	0	Agarwal A, Firdouse M, Brar N, et al. Incidence and Management of Thrombotic and Thromboembolic Complications Following the Superior Cavopulmonary Anastomosis Procedure: A Literature Review. Clin Appl Thromb Hemost. 2018 Apr;24(3):405-415. doi: 10.1177/1076029617739702. Epub 2017 Dec 25.
	28660695	0	Ghanem KM, Dhayni RM, Al-Aridi C, et al. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26694. Epub 2017 Jun 29.
	28640364	0	Chan SL, Yeo W, Mo F, et al. A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma. Cancer. 2017 Oct 15;123(20):3977-3985. doi: 10.1002/cncr.30825. Epub 2017 Jun 22.
	28552474	0	Hepponstall M, Chan A, Monagle P. Anticoagulation therapy in neonates, children and adolescents. Blood Cells Mol Dis. 2017 Sep;67:41-47. doi: 10.1016/j.bcmd.2017.05.008. Epub 2017 May 13.
	28505011	0	Nossair FF, Chan HHW, Gantioqui J, et al. In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma: comparisons using thromboelastography and microscopic visualization of fibrin clot structure. Blood Coagul Fibrinolysis. 2017 Oct;28(7):551-557. doi: 10.1097/MBC.0000000000000639.
	28472942	0	Athale UH, Laverdiere C, Nayiager T, et al. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study. BMC Cancer. 2017 May 4;17(1):313. doi: 10.1186/s12885-017-3306-5.
	28422344	0	Thakor AS, Chung J, Patel P, et al. Use of blood pool agents with steady-state MRI to assess the vascular system. J Magn Reson Imaging. 2017 Jun;45(6):1559-1572. doi: 10.1002/jmri.25636. Epub 2017 Apr 19.
	27879470	0	Agarwal A, Firdouse M, Brar N, et al. Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review. Clin Appl Thromb Hemost. 2017 Nov;23(8):911-921. doi: 10.1177/1076029616679506. Epub 2016 Nov 22.
	27621575	0	Chan SL, Chong CC, Chan AW, et al. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016. World J Gastroenterol. 2016 Aug 28;22(32):7289-300. doi: 10.3748/wjg.v22.i32.7289.
	27497400	0	Rebelo J, Nayan S, Choong K, et al. To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections. Int J Pediatr Otorhinolaryngol. 2016 Sep;88:129-35. doi: 10.1016/j.ijporl.2016.06.013. Epub 2016 Jun 6.
	26977751	0	Chen K, Agarwal A, Tassone MC, et al. Risk factors for central venous catheter-related thrombosis in children: a retrospective analysis. Blood Coagul Fibrinolysis. 2016 Jun;27(4):384-8. doi: 10.1097/MBC.0000000000000557.
	26814167	0	Raghupathy R, Ayyappan S, Prabhakar D, et al. Retrospective study of the incidence and patterns of arterial and venous thrombosis in Chinese versus African American patients with multiple myeloma. Br J Haematol. 2017 Jan;176(2):315-317. doi: 10.1111/bjh.13942. Epub 2016 Jan 26.
	26656898	0	Bhatt MD, Paes BA, Chan AK. How to use unfractionated heparin to treat neonatal thrombosis in clinical practice. Blood Coagul Fibrinolysis. 2016 Sep;27(6):605-14. doi: 10.1097/MBC.0000000000000469.
	26553458	0	Manlhiot C, Gruenwald CE, Holtby HM, et al. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity. J Thorac Cardiovasc Surg. 2016 Feb;151(2):444-50. doi: 10.1016/j.jtcvs.2015.10.003. Epub 2015 Oct 9.
	26071841	0	Wong SS, Hui JW, Chan AW, et al. Irreversible Electroporation of the Femoral Neurovascular Bundle: Imaging and Histologic Evaluation in a Swine Model. J Vasc Interv Radiol. 2015 Aug;26(8):1212-1220.e1. doi: 10.1016/j.jvir.2015.04.023. Epub 2015 Jun 10.
	25656259	0	King DH, Paulson WD, Al-Qaisi M, et al. Volume blood flow, static pressure ratio and venous conductance in native arterio-venous fistulae: three surveillance methods compared. J Vasc Access. 2015 May-Jun;16(3):211-7. doi: 10.5301/jva.5000324. Epub 2015 Jan 30.
	25522812	0	Kumar R, Dawson JE, Chan AK, et al. c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency. Br J Haematol. 2015 Jul;170(1):123-5. doi: 10.1111/bjh.13261. Epub 2014 Dec 19.